Skip to main content
Year archive

Hubei Biocause Heilen Pharmaceutical Co., Ltd. — 2021 filings

All 37 regulatory filings released by Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211) in 2021, sourced directly from the official regulator.

37 Filings
2021 Period
2021 filings (37)
Filing Released Lang
Regulatory Filings
2021-12-30 Chinese
Capital/Financing Update
2021-12-24 Chinese
Regulatory Filings
2021-12-20 Chinese
Regulatory Filings
2021-12-20 Chinese
Regulatory Filings
2021-12-20 Chinese
Regulatory Filings
2021-12-20 Chinese
Regulatory Filings
2021-12-15 Chinese
Capital/Financing Update
2021-12-15 Chinese
Capital/Financing Update
2021-12-13 Chinese
Capital/Financing Update
2021-12-13 Chinese
Regulatory Filings
2021-12-12 Chinese
Capital/Financing Update
2021-12-08 Chinese
Audit Report / Information FY 2021
2021-12-08 Chinese
Regulatory Filings
2021-12-08 Chinese
Capital/Financing Update
2021-12-08 Chinese
Regulatory Filings
2021-12-07 Chinese
Capital/Financing Update
2021-12-01 Chinese
Major Shareholding Notification
2021-12-01 Chinese
Board/Management Information
2021-12-01 Chinese
Capital/Financing Update
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Governance Information
2021-12-01 Chinese
Audit Report / Information H1 2021
2021-12-01 Chinese
Capital/Financing Update
2021-12-01 Chinese
Capital/Financing Update
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Declaration of Voting Results & Voting Rights Announcements
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Capital/Financing Update
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Audit Report / Information H1 2021
2021-12-01 Chinese
Audit Report / Information H1 2021
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Regulatory Filings
2021-12-01 Chinese
Audit Report / Information 9M 2021
2021-12-01 Chinese
Audit Report / Information H1 2020
2021-12-01 Chinese